FDAHealthJanuary 26, 2026
Radnostix — Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml
⚠️ Presence of Particulate Matter: Due to production issues
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- January 26, 2026
Nationwide in the USA and Puerto Rico
What's affected?
- Product
- Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.
- Brand
- SODIUM IODIDE I-131
- Lot code
- Batch I012626R-01, Exp 02/09/2026
Additional details
Batch I012626R-01, Exp 02/09/2026
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 16 units.
Get Health recall alerts
Delivered to your inbox. Free. No account required.